InVivoScribe Technologies Inc (InVivoScribe) is a provider of hematology-oncology testing products and services. The company offer full range of hematology-oncology testing products and services. It’s products include lymphotrack and lymphotrack DX assay kits, and custom assay and reagent development products. InVivoScribe also provides general purpose reagents such as PCR and cDNA reagents, gel detection reagents and ABI fluorescence detection reagents. The company offers PCR-based gene rearrangement, chromosome translocation, and gene mutation research use only testing reagents and controls. It provides its in vitro diagnostic cGMP products for hematology-oncology, RUO assays, analyte specific reagents, and DNA and RNA controls. The company operates through research laboratories located in Japan. InVivoScribe is headquartered in San Diego, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Note: Some sections may be missing if data is unavailable for the company
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company InVivoScribe Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- InVivoScribe Technologies Inc Company Overview
- InVivoScribe Technologies Inc Company Snapshot
- InVivoScribe Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
- InVivoScribe Technologies Inc - Pipeline Analysis Overview
- InVivoScribe Technologies Inc - Key Facts
- InVivoScribe Technologies Inc - Major Products and Services
- InVivoScribe Technologies Inc Pipeline Products by Development Stage
- InVivoScribe Technologies Inc Pipeline Products Overview
- B-cell Clonality Assay Kit
- B-cell Clonality Assay Kit Product Overview
- B-cell Immuno-Oncology Assay Kit
- B-cell Immuno-Oncology Assay Kit Product Overview
- Companion Diagnostic Test - Eprenetapopt
- Companion Diagnostic Test - Eprenetapopt Product Overview
- LeukoStrat CDx FLT3 Mutation Assay - Gilteritinib Fumarate
- LeukoStrat CDx FLT3 Mutation Assay - Gilteritinib Fumarate Product Overview
- LeukoStrat CDx FLT3 Mutation Assay - Quizartinib
- LeukoStrat CDx FLT3 Mutation Assay - Quizartinib Product Overview
- LymphoTrack Dx TRB Assay - PGM
- LymphoTrack Dx TRB Assay - PGM Product Overview
- MiSeqDx - Cancer Diagnostic Test
- MiSeqDx - Cancer Diagnostic Test Product Overview
- NGS Based Hematologic Malignancy Test
- NGS Based Hematologic Malignancy Test Product Overview
- T-cell Clonality Assay Kit
- T-cell Clonality Assay Kit Product Overview
- T-cell Immuno-Oncology Assay Kit
- T-cell Immuno-Oncology Assay Kit Product Overview
- InVivoScribe Technologies Inc - Key Competitors
- InVivoScribe Technologies Inc - Key Employees
- InVivoScribe Technologies Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
Recent Developments
Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bay Area Biotechnology Education Consortium
- Esoterix Inc
- New England Biolabs Inc
